The chief executives of seven pharmaceutical companies will have to answer for the steep cost of medicines before a panel of senators on Tuesday. The tableau of corporate heads raising their right hands to deliver sworn testimony about a growing public health crisis could recall scrutiny of the tobacco industry in Congress in the 1990s.
Trending:
Eli Lilly chief executive escapes drug prices hearing